Cargando…

Characterization of H5N1 Influenza Virus Variants with Hemagglutinin Mutations Isolated from Patients

A change in viral hemagglutinin (HA) receptor binding specificity from α2,3- to α2,6-linked sialic acid is necessary for highly pathogenic avian influenza (AI) virus subtype H5N1 to become pandemic. However, details of the human-adaptive change in the H5N1 virus remain unknown. Our database search o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Yohei, Arai, Yasuha, Daidoji, Tomo, Kawashita, Norihito, Ibrahim, Madiha S., El-Gendy, Emad El-Din M., Hiramatsu, Hiroaki, Kubota-Koketsu, Ritsuko, Takagi, Tatsuya, Murata, Takeomi, Takahashi, Kazuo, Okuno, Yoshinobu, Nakaya, Takaaki, Suzuki, Yasuo, Ikuta, Kazuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Microbiology 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453573/ https://www.ncbi.nlm.nih.gov/pubmed/25852160 http://dx.doi.org/10.1128/mBio.00081-15

Ejemplares similares

Novel Polymerase Gene Mutations for Human Adaptation in Clinical Isolates of Avian H5N1 Influenza Viruses
por: Arai, Yasuha, et al.
Publicado: (2016)

PB2 mutations arising during H9N2 influenza evolution in the Middle East confer enhanced replication and growth in mammals
por: Arai, Yasuha, et al.
Publicado: (2019)

PA Mutations Inherited during Viral Evolution Act Cooperatively To Increase Replication of Contemporary H5N1 Influenza Virus with an Expanded Host Range
por: Arai, Yasuha, et al.
Publicado: (2020)

Infection of Human Tracheal Epithelial Cells by H5 Avian Influenza Virus Is Regulated by the Acid Stability of Hemagglutinin and the pH of Target Cell Endosomes
por: Daidoji, Tomo, et al.
Publicado: (2020)

H9N2 Influenza Virus Infections in Human Cells Require a Balance between Neuraminidase Sialidase Activity and Hemagglutinin Receptor Affinity
por: Arai, Yasuha, et al.
Publicado: (2020)

Frequency of D222G and Q223R Hemagglutinin Mutants of Pandemic (H1N1) 2009 Influenza Virus in Japan between 2009 and 2010
por: Yasugi, Mayo, et al.
Publicado: (2012)

Emerging Antigenic Variants at the Antigenic Site Sb in Pandemic A(H1N1)2009 Influenza Virus in Japan Detected by a Human Monoclonal Antibody
por: Yasugi, Mayo, et al.
Publicado: (2013)

Genetic Compatibility of Reassortants between Avian H5N1 and H9N2 Influenza Viruses with Higher Pathogenicity in Mammals
por: Arai, Yasuha, et al.
Publicado: (2019)

Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
por: Yasugi, Mayo, et al.
Publicado: (2013)

Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2012)

Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2021)

A novel immunochromatographic system for easy-to-use detection of group 1 avian influenza viruses with acquired human-type receptor binding specificity
por: Watanabe, Yohei, et al.
Publicado: (2015)

Multiple polymerase gene mutations for human adaptation occurring in Asian H5N1 influenza virus clinical isolates
por: Arai, Yasuha, et al.
Publicado: (2018)

Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus
por: Yunoki, Mikihiro, et al.
Publicado: (2016)

Acquisition of Human-Type Receptor Binding Specificity by New H5N1 Influenza Virus Sublineages during Their Emergence in Birds in Egypt
por: Watanabe, Yohei, et al.
Publicado: (2011)

Tropism of Pandemic 2009 H1N1 Influenza a Virus
por: Ramadhany, Ririn, et al.
Publicado: (2012)

Development of genus-specific universal primers for the detection of flaviviruses
por: Daidoji, Tomo, et al.
Publicado: (2021)

Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus
por: Ideno, Shoji, et al.
Publicado: (2013)

Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2009)

ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner
por: Isobe, Ayana, et al.
Publicado: (2022)

Stimulation of interferon-β responses by aberrant SARS-CoV-2 small viral RNAs acting as retinoic acid-inducible gene-I agonists
por: Arai, Yasuha, et al.
Publicado: (2022)

Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
por: Onodera, Hiroyuki, et al.
Publicado: (2017)

Discovery of novel low-molecular-weight HIV-1 inhibitors interacting with cyclophilin A using in silico screening and biological evaluations
por: Tian, Yu-Shi, et al.
Publicado: (2012)

Chimeric Newcastle Disease Virus Vectors Expressing Human IFN-γ Mediate Target Immune Responses and Enable Multifaceted Treatments
por: Soliman, Rofaida Mostafa, et al.
Publicado: (2023)

Two Types of Antibodies Are Induced by Vaccination with A/California/2009pdm Virus: Binding near the Sialic Acid-Binding Pocket and Neutralizing Both H1N1 and H5N1 Viruses
por: Ohshima, Nobuko, et al.
Publicado: (2014)

Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1
por: Yunoki, Mikihiro, et al.
Publicado: (2010)

Pharmacophore Modeling and Molecular Docking Studies of potential inhibitors to E6 PBM–PDZ from Human Papilloma Virus (HPV)
por: Tian, Yu-Shi, et al.
Publicado: (2015)

Broad and potent anti-influenza virus spectrum of epigallocatechin-3-O-gallate-monopalmitate
por: Kaihatsu, Kunihiro, et al.
Publicado: (2009)

Viscosity is an important factor of resistance to alcohol-based disinfectants by pathogens present in mucus
por: Hirose, Ryohei, et al.
Publicado: (2017)

Stability of SARS-CoV-2 and influenza virus varies across different paper types
por: Hirose, Ryohei, et al.
Publicado: (2022)

A Cytopathic Effect-Based Tissue Culture Method for HCoV-OC43 Titration Using TMPRSS2-Expressing VeroE6 Cells
por: Hirose, Ryohei, et al.
Publicado: (2021)

Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation
por: Hirose, Ryohei, et al.
Publicado: (2021)

Higher Viral Stability and Ethanol Resistance of Avian Influenza A(H5N1) Virus on Human Skin
por: Bandou, Risa, et al.
Publicado: (2022)

Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability
por: Hirose, Ryohei, et al.
Publicado: (2022)

Three Types of Broadly Reacting Antibodies against Influenza B Viruses Induced by Vaccination with Seasonal Influenza Viruses
por: Hirano, Daisuke, et al.
Publicado: (2018)

Situations Leading to Reduced Effectiveness of Current Hand Hygiene against Infectious Mucus from Influenza Virus-Infected Patients
por: Hirose, Ryohei, et al.
Publicado: (2019)

In silico analysis of enantioselective binding of immunomodulatory imide drugs to cereblon
por: Murai, Takahiro, et al.
Publicado: (2016)

Novel Concepts for Drug Hypersensitivity Based on the Use of Long-Time Scale Molecular Dynamic Simulation
por: Murai, Takahiro, et al.
Publicado: (2016)

Mordred: a molecular descriptor calculator
por: Moriwaki, Hirotomo, et al.
Publicado: (2018)

Infectivity assay for detection of SARS‐CoV‐2 in samples from patients with COVID‐19
por: Hiroi, Satoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_18mbjlv1k7veimrnrvkvtgqevu